Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Guardant Health Inc    GH

GUARDANT HEALTH INC

(GH)
My previous session
Most popular
 SummaryQuotesChartsNewsRatingsCalendarCompany 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/18/2019 03/19/2019 03/20/2019 03/21/2019 03/22/2019 Date
93.5(c) 91.23(c) 88.08(c) 85.055(c) 79.01(c) Last
1 919 095 1 318 676 813 642 1 325 116 1 399 581 Volume
-4.57% -2.43% -3.45% -3.43% -7.11% Change
More quotes
Company
Guardant Health, Inc. is a United States-based company that engages in non-invasive cancer genomic sequencing. The Company is focused on developing diagnostic technologies that can transform cancer from a silent killer into a manageable disease. The Company engages in next-generation sequencing,... 
More about the company
Surperformance© ratings of Guardant Health Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GUARDANT HEALTH INC
03/19GUARDANT HEALTH : Management's Discussion and Analysis of Financial Condition an..
AQ
03/13Vera Bradley and Guardant Health surge while Express falls
AQ
03/12GUARDANT HEALTH : 4Q Earnings Snapshot
AQ
03/12GUARDANT HEALTH, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
03/12GUARDANT HEALTH : Reports Fourth Quarter and Full Year 2018 Financial Results an..
AQ
03/12Guardant Health to Present at the 39th Annual Cowen Health Care Conference
GL
03/12Guardant Health to Report Fourth Quarter and Full Year 2018 Financial Results..
GL
02/27Guardant360 Performance Matches Standard-of-Care Tissue Testing in First-Line..
GL
02/14Guardant Health to Present at the 8th Annual Leerink Partners Global Healthca..
GL
01/08GUARDANT HEALTH : Announces Launch of the LUNAR Assay for Detection of Early-Sta..
AQ
More news
Sector news : Bio Diagnostics & Testing
03/11Regeneron Says FDA Approves Dupixent for Atopic Dermatitis in Adolescents
DJ
03/08Regeneron, Sanofi Get FDA Priority Review for Dupixent
DJ
03/07SHANGHAI RAAS BLOOD PRODUCTS : Spain's Grifols, China's Shanghai RAAS form strat..
RE
03/06GILEAD SCIENCES : Says Once-Daily HIV Regimen Shows Promise in Treating Teens an..
DJ
03/05FDA Approves Controversial Drug for Depression -- Update
DJ
More sector news : Bio Diagnostics & Testing
Chart GUARDANT HEALTH INC
Duration : Period :
Guardant Health Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUARDANT HEALTH INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Managers
NameTitle
Helmy Eltoukhy Chief Executive Officer & Director
AmrAli H. Talasaz Chairman, President & Chief Operations Officer
Derek A. Bertocci CFO, Principal Financial & Accounting Officer
Richard B. Lanman Chief Medical Officer
Samir Kaul Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
GUARDANT HEALTH INC110.19%6 789
GENSCRIPT BIOTECH CORP43.62%3 531
INVITAE CORP--.--%1 990
CAREDX INC46.86%1 541
MIRACA HOLDINGS INC.18.26%1 500
IOVANCE BIOTHERAPEUTICS INC7.91%1 179